These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 12201551)

  • 41. Clinical experience of 153 patients with posterior circulation aneurysms.
    Zhao J; Wang S; Yang L; Zhao Y
    J Clin Neurosci; 2005 Jan; 12(1):17-20. PubMed ID: 15639405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Familial intracranial aneurysms in Camagüey].
    Vega-Basulto SD; Montejo-Montejo J; Silva-AdAn S; Mosqueda-Betancourt G
    Rev Neurol; 2003 Feb 1-15; 36(3):218-23. PubMed ID: 12599150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effectiveness of magnetic resonance angiography for mass screening of unruptured intracranial aneurysms].
    Takahashi E; Haku M; Suzuki Y; Fukagawa K; Iida Y; Yoshida K; Miyakawa M; Izuno T; Sugimori H
    Nihon Koshu Eisei Zasshi; 1997 Jul; 44(7):509-17. PubMed ID: 9314705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Value of magnetic resonance angiography for the detection of intracranial aneurysms in autosomal dominant polycystic kidney disease.
    Huston J; Torres VE; Sulivan PP; Offord KP; Wiebers DO
    J Am Soc Nephrol; 1993 Jun; 3(12):1871-7. PubMed ID: 8338918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Natural history of unruptured cerebral aneurysms of the unoperated and observed cases].
    Matsumoto KM; Oota S; Aoki M; Yoshida J; Taguchi K; Sakaki S; Abekura M; Yoshimine T
    No Shinkei Geka; 2005 Jan; 33(1):35-41. PubMed ID: 15678867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A mathematical model of utility for single screening of asymptomatic unruptured intracranial aneurysms at the age of 50 years.
    Li LM; Bulters DO; Kirollos RW
    Acta Neurochir (Wien); 2012 Jul; 154(7):1145-52. PubMed ID: 22581452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Improved risk counselling possible for patients with unruptured intracranial aneurysms].
    Rinkel GJ
    Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1834-7. PubMed ID: 14533493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patients with polycystic kidney disease would benefit from routine magnetic resonance angiographic screening for intracerebral aneurysms: a decision analysis.
    Butler WE; Barker FG; Crowell RM
    Neurosurgery; 1996 Mar; 38(3):506-15; discussion 515-6. PubMed ID: 8837803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Familial intracranial aneurysms. Review of the literature].
    Lejeune JP
    Neurochirurgie; 1997; 43(5):292-8. PubMed ID: 9686233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetics and aneurysm formation.
    Schievink WI
    Neurosurg Clin N Am; 1998 Jul; 9(3):485-95. PubMed ID: 9668181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening for unruptured intracranial aneurysms in autosomal dominant polycystic kidney disease.
    Wiebers DO; Torres VE
    N Engl J Med; 1992 Sep; 327(13):953-5. PubMed ID: 1513354
    [No Abstract]   [Full Text] [Related]  

  • 52. MR Angiography Screening and Surveillance for Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Cost-effectiveness Analysis.
    Malhotra A; Wu X; Matouk CC; Forman HP; Gandhi D; Sanelli P
    Radiology; 2019 May; 291(2):400-408. PubMed ID: 30777807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography.
    Ruggieri PM; Poulos N; Masaryk TJ; Ross JS; Obuchowski NA; Awad IA; Braun WE; Nally J; Lewin JS; Modic MT
    Radiology; 1994 Apr; 191(1):33-9. PubMed ID: 8134594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for intracranial aneurysms in high-risk relatives.
    Lindbloom EJ
    J Fam Pract; 2000 Feb; 49(2):184-5. PubMed ID: 10718699
    [No Abstract]   [Full Text] [Related]  

  • 55. Familial intracranial aneurysms.
    Ronkainen A; Hernesniemi J; Puranen M; Niemitukia L; Vanninen R; Ryynänen M; Kuivaniemi H; Tromp G
    Lancet; 1997 Feb; 349(9049):380-4. PubMed ID: 9033463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Screening for cerebral aneurysms in the ADPKD population: mandatory or potentially harmful?].
    Magistroni R; Palmieri L; Scolari F
    G Ital Nefrol; 2011; 28(6):582-7. PubMed ID: 22167609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The case for family screening for intracranial aneurysms.
    Chalouhi N; Chitale R; Jabbour P; Tjoumakaris S; Dumont AS; Rosenwasser R; Gonzalez LF
    Neurosurg Focus; 2011 Dec; 31(6):E8. PubMed ID: 22133176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Observation of statistics of screening for unruptured cerebral aneurysms in Tochigi prefecture].
    Matsumoto E; Shinoda S; Masuzawa T; Nakamura K
    No Shinkei Geka; 2002 Aug; 30(8):829-36. PubMed ID: 12187728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intracranial aneurysm screening: indications and advice for practice.
    Rinkel GJ
    Lancet Neurol; 2005 Feb; 4(2):122-8. PubMed ID: 15664544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening for intracranial aneurysms in patients with isolated polycystic liver disease.
    Schievink WI; Spetzler RF
    J Neurosurg; 1998 Nov; 89(5):719-21. PubMed ID: 9817407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.